SCHEMBL8887119

SCHEMBL8887119

CC(CCCOc1ccc2ncc(-c3cccc(F)c3)cc2c1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.47
PDGFRA P16234 1/20 0.47
LTB4R Q15722 10/20 0.46
DPP4 P27487 1/20 0.43
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
P2RY12 Q9H244 1/20 0.43
PPARG P37231 3/20 0.42
PPARA Q07869 3/20 0.42
CYSLTR2 Q9NS75 1/20 0.41
CYSLTR1 Q9Y271 1/20 0.41
PPARD Q03181 1/20 0.41
DHODH Q02127 1/20 0.40
GRIN2B Q13224 1/20 0.40
MAP4K4 O95819 1/20 0.40
CSNK1G2 P78368 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
MAP4K5 Q9Y4K4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8887112 0.82 PDGFRB (0.45) PDGFRBPDGFRADPP4PDE3BPDE3A
SCHEMBL8499648 0.82 PDE3B (0.55) PDGFRBPDGFRALTB4RPDE3BPDE3A
SCHEMBL8499652 0.82 PPARG (0.54) PDGFRBPDGFRADPP4PPARGPPARA
SCHEMBL8889522 0.81 PDGFRB (0.47) PDGFRBPDGFRADPP4PPARGPPARA
SCHEMBL8501414 0.80 PDE3B (0.58) PDGFRBPDGFRALTB4RPDE3BPDE3A
SCHEMBL8502489 0.79 PDGFRB (0.52) PDGFRBPDGFRAPDE3BPDE3AP2RY12
SCHEMBL8501205 0.78 PDGFRB (0.51) PDGFRBPDGFRADPP4DHODHGRIN2B
SCHEMBL8501209 0.78 AKR1C3 (0.60) PDGFRBPDGFRAMAP4K4CSNK1G2CLK4
Hydrochloric Acid SCHEMBL8503310 0.77 PDGFRB (0.52) PDGFRBPDGFRAPDE3BPDE3AP2RY12
Hydrochloric Acid SCHEMBL8504144 0.76 PDGFRB (0.51) PDGFRBPDGFRAGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US claimed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed